Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA ...

November is Pulmonary Hypertension Awareness Month, and the American Lung Association, with support from Merck, is raising ...

Abstract: Pulmonary hypertension (PH) is a fatal pulmonary vascular disease. The standard diagnosis of PH heavily relies on an invasive technique, i.e., right heart catheterization, which leads to a ...

Simple task management app enhanced with home blood pressure (BP) tracking. Integrates features from Harvard Health: https://www.health.harvard.edu/heart-health/track ...

Pulmonary arterial hypertension (PAH) is a progressive and life-threatening cardiopulmonary disorder with rising global prevalence and limited curative options. Although current therapies have ...

A new sequential strategy successfully treats people with severe chronic thromboembolic pulmonary hypertension (CTEPH), significantly reducing high blood pressure and improving heart function, a study ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

In children born at high altitude, lung development is affected by hypoxia, which can lead to pulmonary hypertension and right ventricular failure. Animal models of postnatal, transient, hypoxia ...

Introduction: Heart failure often involves right ventricular (RV) dysfunction due to pulmonary arterial hypertension (PAH), significantly influencing prognosis. However, RV dysfunction is frequently ...

Background: Patients with pulmonary embolism (PE) at high altitude face an increased risk of developing chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to establish a diagnosis ...